Evidence map›Paper›PMID 37669371›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Mimicking superinfection exclusion disrupts alphavirus infection and transmission in the yellow fever mosquito

Christine M Reitmayer, Emily Levitt, Sanjay Basu, Barry Atkinson, Rennos Fragkoudis, Andres Merits, Sarah Lumley, Will Larner, Adriana V Diaz, Sara Rooney and 4 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 2 countries.

Christine M ReitmayerArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0002-5386-0616
Emily LevittArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Sanjay BasuArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0003-2098-7423
Barry AtkinsonArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0002-1348-7204
Rennos FragkoudisArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Andres MeritsApplied Virology, Institute of Technology, University of Tartu, Tartu 50411, Estonia.ORCID 0000-0001-8193-0071
Sarah LumleyArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0002-8605-3650
Will LarnerArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Adriana V DiazArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0002-8272-0428
Sara RooneyArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Callum J E ThomasArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Katharina von WyschetzkiArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.
Kai RausaluApplied Virology, Institute of Technology, University of Tartu, Tartu 50411, Estonia.
Luke AlpheyArthropod Genetics, The Pirbright Institute, Pirbright, Woking GU24 0NF, United Kingdom.ORCID 0000-0002-2916-3802
The Pirbright Institute · GBEdinburgh Genomics · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007033Biotechnology and Biological Sciences Research Council BBS/E/I/00007038Biotechnology and Biological Sciences Research Council BBS/E/I/00007039
6 · The paper itself

Abstract

Multiple viruses, including pathogenic viruses, bacteriophages, and even plant viruses, cause a phenomenon termed superinfection exclusion whereby a currently infected cell is resistant to secondary infection by the same or a closely related virus. In alphaviruses, this process is thought to be mediated, at least in part, by the viral protease (nsP2) which is responsible for processing the nonstructural polyproteins (P123 and P1234) into individual proteins (nsP1-nsP4), forming the viral replication complex. Taking a synthetic biology approach, we mimicked this naturally occurring phenomenon by generating a superinfection exclusion-like state in

Indexed as

AedesAlphavirus InfectionsChikungunya virusSuperinfectionYellow FeverAnimalsSindbis Virusalphavirusesarbovirus transmissionnsP2 proteasesuperinfection exclusion

Identifiers

PMID37669371
PMCPMC10500260
OpenAlexW4386452960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.